ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
DERMA SCIENCES
(NQ:
DSCI
)
13.43
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
13.50
Bid (Size)
13.43 (500)
Ask (Size)
13.48 (4400)
Prev. Close
13.43
Today's Range
13.34 - 13.53
52wk Range
9.090 - 14.92
Shares Outstanding
16,976,659
Dividend Yield
N/A
Featured News
More News
Drug stocks inch higher; Derma rallies
May 25, 2011
Shares of Derma Sciences jump after a positive study for the company’s treatment for diabetic foot ulcers.
Read More
category
Computer Software
,
Biotechnology
,
DSCI
, and 14 more.
from
MarketWatch
Merck’s slides weighs on drug stocks
February 03, 2011
The drug sector keys on Merck’s fourth-quarter loss and a disappointing profit outlook.
Read More
category
Earnings
,
Biotechnology
,
DSCI
, and 13 more.
from
MarketWatch
More News
Read More
Published Research Concludes Total Contact Casting is More Effective in Healing Diabetic Foot Ulcers Than Other Standards of Care
June 12, 2013
from
Business Wire News Releases
Derma Sciences (DSCI) Says No PK Parameters Could Be Calculated in Latest Study
June 12, 2013
from
StreetInsider.com News Articles
Derma Sciences Reports Results from DSC127 Pharmacokinetic Study
June 12, 2013
from
Business Wire News Releases
Derma Sciences to Webcast June 12 Analyst Day
June 07, 2013
from
Business Wire News Releases
Derma Sciences Appoints Medical Device Veteran Amy S. Paul to Its Board of Directors
May 24, 2013
from
Business Wire News Releases
DSCI January 2014 Options Begin Trading
May 20, 2013
category
Stocks
from
Market News Video
Investment Ideas in the Expanding Wound Care Market
May 17, 2013
from
ACCESSWIRE
Derma Sciences (DSCI) Posts Q1 Loss of 38c/Share
May 16, 2013
from
StreetInsider.com News Articles
Derma Sciences Reports First Quarter 2013 Financial Results
May 16, 2013
from
Business Wire News Releases
Earnings Scheduled For May 16, 2013
May 16, 2013
category
JWN
,
Earnings
,
DANG
, and 30 more.
from
Latest Articles from Benzinga.com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
2
The Future of Android Looks More Like Apple Inc.
Mike Schuster
3
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
4
The Waning Integrity of US Financial Markets
Todd Harrison
5
Tech News: Tesla Motors Inc's First Recall Is a Display of Public Relations Prowess
Josh Wolonick
See All Articles
»